Uveal and conjunctival melanomas : disease course and outcomes in Chinese patients

INTRODUCTION: Epidemiological studies of ocular melanomas have largely focused on Caucasian populations. This study reviewed the course and outcomes of uveal melanoma (UM) and conjunctival melanoma (CM) in Chinese patients.

METHODS: This retrospective study included patients with UM and CM who received treatment in a tertiary eye centre in Hong Kong from January 1994 to December 2019. Data were recorded concerning patient demographics, tumour laterality, tumour characteristics, investigations performed, treatment regimen, and final outcomes.

RESULTS: During the 25-year study period, there were 13 patients with UM and 11 patients with CM who did not display nodal or systemic involvement at diagnosis. The mean ± standard deviation ages at diagnosis of UM and CM were 59 ± 15.8 and 57 ± 13.9 years, respectively. There were more men among patients with UM than among those with CM (P=0.042). Most patients with UM underwent primary enucleation (n=12; 92.3%), whereas most patients with CM underwent orbital exenteration (n=9; 81.8%). The prognosis was significantly worse for CM than for UM. The median disease-free survival were 5.2 years (range, 0.7-20.5) and 2.1 years (range, 0.1-24.9) for UM and CM, respectively. Melanoma-related mortality was significantly higher among patients with CM than among those with UM (P=0.006).

CONCLUSION: Compared with UM, CM has higher rates of systemic metastasis and tumour-related mortality in Hong Kong Chinese patients, regardless of prior definitive treatment.

Medienart:

E-Artikel

Erscheinungsjahr:

2023

Erschienen:

2023

Enthalten in:

Zur Gesamtaufnahme - volume:29

Enthalten in:

Hong Kong medical journal = Xianggang yi xue za zhi - 29(2023), 6 vom: 02. Dez., Seite 506-513

Sprache:

Englisch

Beteiligte Personen:

Chan, J Y Y [VerfasserIn]
Lam, S C [VerfasserIn]
Yuen, H K L [VerfasserIn]

Links:

Volltext

Themen:

Asian Continental Ancestry Group
Conjunctival neoplasms
Journal Article
Melanoma
Uveal neoplasms

Anmerkungen:

Date Completed 25.12.2023

Date Revised 25.12.2023

published: Print-Electronic

Citation Status MEDLINE

doi:

10.12809/hkmj219451

funding:

Förderinstitution / Projekttitel:

PPN (Katalog-ID):

NLM365353124